Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 18.73B | 20.73B | 21.60B | 22.15B | 18.47B | 21.85B |
Gross Profit | 5.08B | 5.91B | 6.74B | 4.44B | 5.09B | 5.95B |
EBITDA | -325.00M | 896.00M | 1.48B | -425.00M | 810.00M | 1.02B |
Net Income | -1.09B | 235.00M | 679.00M | -1.07B | 178.00M | 444.00M |
Balance Sheet | ||||||
Total Assets | 31.22B | 28.84B | 30.61B | 28.96B | 27.40B | 25.02B |
Cash, Cash Equivalents and Short-Term Investments | 3.42B | 4.20B | 6.78B | 4.48B | 5.66B | 6.13B |
Total Debt | 10.70B | 9.70B | 8.27B | 8.29B | 7.81B | 5.52B |
Total Liabilities | 19.30B | 15.18B | 16.93B | 16.25B | 13.69B | 11.54B |
Stockholders Equity | 11.92B | 13.66B | 13.69B | 12.71B | 13.71B | 13.49B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -3.85B | 2.65B | -1.52B | -2.60B | 434.00M |
Operating Cash Flow | 0.00 | -3.52B | 2.96B | -1.19B | -1.62B | 1.16B |
Investing Cash Flow | 0.00 | -527.00M | -778.00M | -335.00M | -985.00M | -728.00M |
Financing Cash Flow | 0.00 | 1.10B | -246.00M | 272.00M | 2.06B | -708.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥44.12B | 12.21 | 5.92% | 3.23% | -22.14% | ||
80 Outperform | ¥24.00B | 6.81 | 0.74% | 7.38% | 25.90% | ||
80 Outperform | ¥4.11B | 4.02 | ― | 3.30% | 36.77% | ||
74 Outperform | ¥42.11B | 14.27 | 3.95% | -1.34% | -14.87% | ||
63 Neutral | $33.61B | 6.06 | -11.53% | 1.82% | 5.53% | -18.79% | |
60 Neutral | ¥3.92B | 16.72 | 1.96% | -4.02% | -65.53% | ||
58 Neutral | ¥6.26B | 29.46 | 2.96% | -1.17% | ― |